Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

DNA damage-induced Leukaemic Stem and Progenitor Cell Kill with Mylotarg and Tipifarnib/Zarnestra Drug Combination In Acute Myeloid Leukemia (AML)

Mays Jawad, PhD, Ning Yu, Nigel H. Russell, MD, Monica Pallis, PhD

Blood (2010) 116 (21): 1824.

https://doi.org/10.1182/blood.V116.21.1824.1824

Published: 2010

Journal Articles

The Hypomethylating Agent 5-Azacytidine Can Target Leukaemic Stem and Progenitor Cells In Acute Myeloid Leukemia (AML) by Inducing DNA Damage and Stress Response Pathways

Mays Jawad, PhD, Ning Yu, Nigel H. Russell, MD, Monica Pallis, PhD

Blood (2010) 116 (21): 292.

https://doi.org/10.1182/blood.V116.21.292.292

Published: 2010

Journal Articles

Azacytidine and Gemtuzumab Ozogamicin Co-Operate to Inhibit the Wnt Pathway and Increase Cytotoxicity in AML

Mays Jawad, BSc, PhD, Nigel H. Russell, MD, Monica Pallis, PhD

Blood (2008) 112 (11): 2991.

https://doi.org/10.1182/blood.V112.11.2991.2991

Published: 2008

Journal Articles

In Vitro Chemosensitivity of Leukaemic Stem and Progenitor Cells to Gemtuzumab Ozogamicin (Mylotarg) in AML.

Mays Jawad, PhD, Ullas Mony, MSC, Nigel H. Russell, MBChB, Monica Pallis, PhD

Blood (2007) 110 (11): 650.

https://doi.org/10.1182/blood.V110.11.650.650

Published: 2007

Journal Articles

Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy-related acute myeloid leukemia

Mays Jawad, Claire Helen Seedhouse, Nigel Russell, Mark Plumb

Blood (2006) 108 (12): 3916–3918.

https://doi.org/10.1182/blood-2006-05-022921

Published: 2006

Journal Articles

Polymorphisms in Human Homeobox HLX1 and DNA Repair RAD51 Genes Increase the Risk of Therapy-Related Acute Myeloid Leukemia.

Mays Jawad, PhD, Claire Seedhouse, PhD, Nigel H. Russell, MD, Mark Plumb, PhD

Blood (2006) 108 (11): 1171.

https://doi.org/10.1182/blood.V108.11.1171.1171

Published: 2006

Journal Articles

Defined Bone Marrow Niche Components Mediate the In Vitro Resistance of Acute Myeloid Leukaemic Stem and Progenitor Cells (LSPC) to Cytosine Arabinoside.

Ullas Mony, Mays Jawad, PhD, Nigel H. Russell, MD, Monica Pallis, PhD

Blood (2006) 108 (11): 2543.

https://doi.org/10.1182/blood.V108.11.2543.2543

Published: 2006

Journal Articles

A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay

Jill Brown, Mays Jawad, Stephen R. F. Twigg, Kaan Saracoglu, Axel Sauerbrey, Angela E. Thomas, Roland Eils, Jochen Harbott, Lyndal Kearney

Blood (2002) 99 (7): 2526–2531.

https://doi.org/10.1182/blood.V99.7.2526

Published: 2002

NARROW

DNA damage-induced Leukaemic Stem and Progenitor Cell Kill with Mylotarg and Tipifarnib/Zarnestra Drug Combination In Acute Myeloid Leukemia (AML)

The Hypomethylating Agent 5-Azacytidine Can Target Leukaemic Stem and Progenitor Cells In Acute Myeloid Leukemia (AML) by Inducing DNA Damage and Stress Response Pathways

Azacytidine and Gemtuzumab Ozogamicin Co-Operate to Inhibit the Wnt Pathway and Increase Cytotoxicity in AML

In Vitro Chemosensitivity of Leukaemic Stem and Progenitor Cells to Gemtuzumab Ozogamicin (Mylotarg) in AML.

Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy-related acute myeloid leukemia

Polymorphisms in Human Homeobox HLX1 and DNA Repair RAD51 Genes Increase the Risk of Therapy-Related Acute Myeloid Leukemia.

Defined Bone Marrow Niche Components Mediate the In Vitro Resistance of Acute Myeloid Leukaemic Stem and Progenitor Cells (LSPC) to Cytosine Arabinoside.

A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only